mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.18 |
0.0006 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.002 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.003 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.004 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.004 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |